Exploring potential working mechanisms of accelerated HF-rTMS in refractory major depression with a focus on locus coeruleus connectivity

• Published in: European psychiatry Vol. 67; no. 1; p. e70
• Main Authors: Wu, Guo-Rong, Baeken, Chris
• Format: Journal Article
• Language: English
• Published: England Cambridge University Press 17.10.2024
• Subjects: accelerated rTMS; Adult; Antidepressants; Brain research; Brain-derived neurotrophic factor; Clinical outcomes; Depressive Disorder, Major - physiopathology; Depressive Disorder, Major - therapy; Depressive Disorder, Treatment-Resistant - physiopathology; Depressive Disorder, Treatment-Resistant - therapy; Dorsolateral Prefrontal Cortex; Drug therapy; Electric fields; Electroconvulsive therapy; Female; Humans; locus coeruleus; Locus Coeruleus - physiopathology; Magnetic Resonance Imaging; major depressive disorder; Male; Mental depression; Middle Aged; Neurobiology; Neurogenesis; Prefrontal Cortex - physiopathology; Psychotropic drugs; Transcranial Magnetic Stimulation - methods; Treatment Outcome; major depressive disorder; locus coeruleus; accelerated rTMS
• ISSN: 0924-9338; 1778-3585; 1778-3585
• DOI: 10.1192/j.eurpsy.2024.1769

This study investigates the effects of accelerated high-frequency repetitive transcranial magnetic stimulation (aHF-rTMS), applied to the left dorsolateral prefrontal cortex (DLPFC), on locus coeruleus (LC) functional connectivity in the treatment of refractory medication-resistant major depression (MRD). We studied 12 antidepressant-free refractory MRD patients, focusing on how aHF-rTMS affects the LC, a central component of the brain's noradrenergic system and key to mood regulation and stress response. A stronger decrease in LC functional connectivity following aHF-rTMS treatment resulted in better clinical improvement. We observed such LC functional connectivity decreases with several brain regions, including the superior frontal gyrus, precentral gyrus, middle occipital gyrus, and cerebellum. Moreover, our exploratory analyses hint at a possible role for E-field modeling in forecasting clinical outcomes. Additional analyses suggest potential genetic and dopaminergic factors influencing changes in LC functional connectivity in relation to clinical response. The findings of this study underscore the pivotal role of the LC in orchestrating higher cognitive functions through its extensive connections with the prefrontal cortices, facilitating decision-making, influencing attention, and addressing depressive rumination. Additionally, the observed enhancement in LC-(posterior) cerebellar connectivity not only highlights the cerebellum's role in moderating clinical outcomes through noradrenergic system modulation but also suggests its potential as a predictive marker for aHF-rTMS efficacy. These results reveal new insights into the neural mechanisms of refractory depression and suggest therapeutic targets for enhancing noradrenergic activity, thereby addressing both cognitive and psychomotor symptoms associated with the disorder.